Binding of TGF-β1 latency-associated peptide (LAP) to αvβ6 integrin modulates behaviour of squamous carcinoma cells

British Journal of Cancer

Volumn 87, Issue 8, 2002, Pages 859-867

  Thomas, G J ^a   Hart, I R ^a   Speight, P M ^a   Marshall, J F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Adhesion; Integrins; Invasion; LAP; Migration; MMP 9; Squamous carcinoma; TGF 1

Indexed keywords

ARGININE; ASPARTIC ACID; GLYCINE; INTEGRIN; LATENCY ASSOCIATED PEPTIDE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ALPHAVBETA6 INTEGRIN; COLLAGEN; FIBRONECTIN; GELATINASE B; LAMININ; MATRIGEL; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; PROTEOGLYCAN; TUMOR ANTIGEN;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL ADHESION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; CANCER INVASION; CELL DIVISION; CELL LINE; CELL MOTION; DRUG ANTAGONISM; DRUG COMBINATION; ENZYME ACTIVATION; GENETIC TRANSFECTION; METABOLISM; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL DIVISION; CELL LINE; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; ENZYME ACTIVATION; FIBRONECTINS; HUMANS; INTEGRINS; LAMININ; MATRIX METALLOPROTEINASE 9; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTEOGLYCANS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 0037037304     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600545     Document Type: Article

References (44)

1. Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S, Baker MS (2002) Overexpression of alphavbeta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 23: 237-244
2. Akhurst RJ, Balmain A (1999) Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol 187: 82-90
3. Akhurst RJ, Derynck R (2001) TGF-beta signaling in cancer - A double-edged sword. Trends Cell Biol 11: S44-S51
4. Annes JP, Rifkin DB, Munger JS (2002) The integrin αvβ6 binds and activates latent TGFβ3. FEBS 511: 65-68
5. Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y (2000) Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer 7: 19-26
6. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pitte JF, Nishimura SL, Aldape K, Landers DV, Carpenter W, Gillet N, Sheppard D, Matthay MA, Albelda SM, Kramer RH, Pytela R (1995) Expression of the β6 subunit in development, neoplasia and tissue repair suggests a role in epithelial remodelling. J Cell Sci 108: 2241-2251
7. 51Cr-release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In In Vitro Methods in Cell-Mediated and Tumour Immunity, Bloom BR, David JHR (eds) pp 423-436 New York: Academic Press
8. Busk M, Pytela R, Sheppard D (1992) Characterisation of the integrin αvβ6 as a fibronectin-binding protein. J Biol Chem 269: 5790-5796
9. Derynck R, Akhurst RJ, Balmain A (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129
10. Eisma RJ, Spiro JD, von Biberstein SE, Lindquist R, Kreutzer DL (1996) Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells. Am J Surg 172: 641-645
11. Fahey MS, Paterson IC, Stone A, Collier AJ, Heung YL, Davies M, Patel V, Parkinson EK, Prime SS (1996) Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts. Br J Cancer 74: 1074-1080
12. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M (1995) Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987
13. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB (1997) TGF-beta latency: Biological significance and mechanisms of activation. Stem Cells 15: 190-197
14. Hamidi S, Salo T, Kainulainen T, Epstein J, Lerner K, Larjava H (2000) Expression of alpha (v) beta 6 integrin in oral leukoplakia. Br J Cancer 82: 1433-1440
15. Huang X, Wu J, Spong S, Sheppard D (1998) The integrin alpha v beta 6 is critical for keratinocyte migration on both its known ligand, fibronectin and on vitronectin. J Cell Sci 111: 2189-2195
16. Johnsen M, Lund LR, Romer J, Almholt K, Dano K (1998) Cancer invasion and tissue remodeling: Common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671
17. Jones J, Sugiyama M, Speight PM, Watt FM (1996) Restoration of αvβ5 integrin in neoplastic keratinocytes results in increased capacity for terminal differentiation and suppression of anchorage independent growth. Oncogene 12: 119-126
18. Jones J, Watt FM, Speight PM (1997) Changes in the expression of αv integrins in oral squamous cell carcinoma. J Oral Pathol Med 26: 63-68
19. Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, Hyckel P, Zardi L, Katenkamp D (1999) Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 81: 1071-1079
20. Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B (1996) Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21wafl induction are important early events. Cell Growth Differ 7: 1291-1304
21. Massague J, Blain SW, Lo RS (2000) TGF beta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309
22. Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA (1997) Human tenascin-C: Identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 72: 236-240
23. Munger JS, Harpel JG, Giancotti FG, Rifkin DB (1998) Interactions between growth factors and integrins: Latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell 9: 2627-2638
24. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328
25. Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Munoz-Antonia T (2001) Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Clin Cancer Res 7: 1618-1626
26. Park BJ, Park JI, Byun DS, Park JH, Chi SG (2000) Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res 60: 3031-3038
27. Pasche B (2001) Role of transforming growth factor beta in cancer. J Cell Physiol 186: 153-168
28. Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS (2002) TGF-beta 1 acts as a tumour suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Oncogene 21: 1616-1624
29. Paterson IC, Matthews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK, Prime SS (2001) Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. J Pathol 193: 458-467
30. Paterson IC, Patel V, Sandy JR, Prime SS, Yeudall WA (1995) Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes. Br J Cancer 72: 922-927
31. Prieto AL, Edelman GM, Crossin KL (1993) Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 90: 10154-10158
32. Prime SS, Nixon SVR, Crane IJ, Stone A, Matthews JB, Maitland NJ, Remnant L, Powell SK, Game SM, Scully C (1990) The behaviour of human oral squamous cell carcinoma in culture. J Pathol 160: 259-269
33. Ramos DM, Chen B, Regezi J, Zardi L, Pytela R (1998) Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 75: 680-687
34. Rumsby G, Carter RL, Gusterson BA (1990) Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 61: 365-368
35. Sugiyama M, Speight PM, Prime SS, Watt FM (1993) Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinoma. Carcinogenesis 14: 2171-2176
36. Taipale J, Saharinen J, Hedman K, Keski-Oja J (1996) Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44: 875-889
37. Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM, Marshall JF (2001a) Alpha v beta 6 integrin Upregulates Matrix Metalloproteinase 9 and Promotes Migration of Normal Oral Keratinocytes. J Invest Dermatol 116: 898-904
38. Thomas GJ, Lewis MP, Whawell SA, Russel A, Hart IR, Speight PM, Marshall JF (2001b) αvβ6 integrin promotes invasion and migration in squamous carcinoma cells. J Invest Dermatol 117: 67-73
39. Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM (2001c) Alpha V beta 6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 92: 641-650
40. Wakefield LM, Roberts AB (2002) TGF-beta signaling: Positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29
41. Wang D, Song H, Evans JA, Lang JC, Schuller DE, Weghorst CM (1997) Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 18: 2285-2290
42. Weinacker A, Chen A, Agrez M, Cone RI, Nishimura S, Wayner EA, Pytela R, Sheppard D (1994) Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem 269: 6940-6948
43. Xue H, Atakilit A, Zhu W, Li X, Ramos DM, Pytela R (2001) Role of the alphavbeta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun 288: 610-618
44. Yeudall WA, Torrance LK, Elsegood KA, Speight P, Scully C, Prime SS (1993) Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions. Eur J Cancer B Oral Oncol 29B: 63-67